Mosaic expression of uncein and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa

British Journal of Dermatology

Volumn 136, Issue 5, 1997, Pages 757-761

  Matsumura, Y ^a   Horiguchi, Y ^b   Toda, K ^a   Fujii, H ^a   Kore Eda, S ^a   Tachibana, T ^a   Ohta, K ^a   Okamoto, H ^a   Imamura, S ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTEGRIN; KALININ;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; EPIDERMOLYSIS BULLOSA; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0030975079     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03666.x     Document Type: Article

References (33)

1. Lane EB, Rugg EL, Navsaria H et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992; 356: 244-6.
2. Hovnanian A, Pollack E, Hilal L et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nature Genet 1993; 3: 327-32.
3. Uitto J, Christiano AM. Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol Res 1994; 287: 16-22.
4. Aberdam D, Galliano MF, Vailly J et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMININ-5). Nature Genet 1994; 6: 299-304.
5. Vidal F, Aberdam D, Miquel C et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nature Genet 1995; 10: 229-34.
6. Jonkman MF, de Jong MCJM, Heeres K et al. 180 kDa bullous pemphigoid antigen (BP108) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 1995; 95: 1345-52.
7. Jonkman MF, de Jong MCJM, Heeres K et al. Generalized atrophic benign epidermolysis bullosa: Either 180-kDa bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol. 1996; 132: 145-50.
8. Fine J-D, Horiguchi Y, Couchman JR. 19-DEJ-1: a hemidesmosome-anchoring filament complex-associated monoclonal antibody: definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Arch Dermatol 1989; 125: 520-3.
9. Pulkkinen L, Christiano AM, Airenne T et al. Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nature Genet 1994; 6: 293-8.
10. McGrath JA, Pulkkinen L, Christiano AM et al. Altered laminin 5 expression due to mutations in the gene encoding the β3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1995; 104: 467-74.
11. McGrath JA, Christiano AM, Pulkkinen L et al. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermoloysis bullosa. J Invest Dermatol 1996; 106: 1157-9.
12. McGrath JA, Gatalica B, Christiano AM et al. Mutations in the 180-kDa bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nature Genet 1995; 11: 83-6.
13. McGrath JA, Gatalica B, Li K et al. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996; 148: 1787-96.
14. McGrath JA, Darling T, Gatalica B et al. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized benign atrophic epidermolysis bullosa. J Invest Dermatol 1996; 106: 771-4.
15. Daring T, McGrath JA, Yee C et al. Mutations in the bullous pemphigoid antigen 2 (BPAG2) gene in live Austrian families with generalized atrophic benign epidermolysis bullosa (GABEB). J Invest Dermatol 1996; 106: 842 (abstract).
16. Fine J-D, Horiguchi Y, Jester J et al. Detection and partial characterization of a midlamina lucida-hemidesmosome-associated antigen (19-DEJ-1) present within human skin. J Invest Dermatol 1989; 92: 825-30.
17. Zhang X-M, Horiguchi Y, Ueda M et al. 1-2B7B: monoclonal antibody reacting to the 120-kDa polypeptide component of human epidermal hemidesmosomes. Arch Dermatol Res 1991; 283: 310-16.
18. Zhang X-M, Horiguchi Y, Ueda M et al. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease. J Dermatol Sci 1992; 3: 46-55.
19. Nishizawa Y, Uematsu J, Owaribe K. HD4, a 180kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (Tokyo) 1993; 113: 493-501.
20. Küstala U, Mustakallio KK. Dermo-epidermal separation with suction: electron microscopic and histochemical study of initial events of blistering on human skin. J Invest Dermatol 1967; 48: 466-77.
21. Horiguchi Y, Abrahamson D, Fine J-D. Epitope mapping of the laminin molecule in murine skin basement membrane zone: demonstration of spatial differences in ultrastructural localization. J Invest Dermatol 1991; 96: 309-13.
22. Sonnenberg A, Calafat J, Janssen H et al. Integrin α6/β4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991; 113: 907-17.
23. Bauer EA, Kim YH, Woodley DT et al. Epidermolysis bullosa: recent advances in understanding pathogenetic mechanisms. Curr Probl Dermatol 1992; 4: 109-19.
24. Verrand P, Hsi BL, Yeh C-J et al. Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res 1987; 170: 116-28.
25. Carter WG, Ryan MC, Gahr PJ. Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes. Cell 1991; 65: 599-610.
26. Rousselle P, Lunstrum GP, Keene DR et al. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 1991; 114: 567-76.
27. Uitto J, Pulkkinen L, Christiano AM. Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes. Invest Dermatol 1994; 103: 39S-46S.
28. Li K, Guidice GJ, Tamai K et al. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone. J Invest Dermatol 1992; 99: 258-63.
29. Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen. BP180. J Clin Invest 1993; 92: 2480-8.
30. Zeng L, Daniels A, Riddelle K, Fine J-D. Uncein, an anchoring filament component, is biochemically similar to kalinin but differs markedly in its in vitro expression by normal human keratinocyte monolayers. J Invest Dermatol 1994; 102: 535 (abstract).
31. Zeng L, Riddelle K, Daniels A et al. Molecular cloning of uncein, an anchoring filament protein abnormally expressed in all junctional epidermolysis bullosa (JEB) skin-partial sequencing of a completely novel gene. J Invest Dermatol 1995; 104: 582 (abstract).
32. Horiguchi Y, Ueda M, Shimizu H et al. An acquired bullous dermatosis due to an autoimmune reaction against uncein. Br J Dermatol 1996; 134: 934-8.
33. Pohla-Gubo G, Lazarova Z, Giudice GJ et al. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol 1995; 4: 199-206.